Sponsor:
BAMF Health
Code:
NCT05558956
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
illuccix 68Ga-PSMA-11 Total Body PET-CT
Brief summary:
Conditions
Metastatic Castration-resistant Prostate Cancer
Study ID
NCT05558956
Start date
Nov 1, 2022
Status verified date
Mar, 2023
Completion date
Dec, 2023
Anticipated
Primary completion date
Dec, 2023
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
experimental: Low Dose
experimental: High dose
Interventions
illuccix 68Ga-PSMA-11 Total Body PET-CT
Primary outcome measure
Central contacts
Locations
BAMF Health
Recruiting
Grand Rapids, Michigan, United States, 49503
Contacts
Sponsor
BAMF Health
Last update posted
Jul 27, 2023
Last verified
Mar, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by BAMF Health on 2023-07-27.